@article{008b3135c7364c3c8c933b1a9b8b2d0f,
title = "Review of the ICD Registry's Third Year, Expansion to include Lead Data and Pediatric ICD Procedures, and Role for Measuring Performance",
abstract = "The National ICD Registry has proven to be a successful partnership between HRS and ACCF collecting data from over 339,076 ICD implantation procedures from 1,432 hospitals and 4,563 implanting physicians in 2006-2008. Data accuracy is evaluated through the Data Quality Reporting process and onsite audit program. Quarterly benchmarking reports have allowed each hospital to assess its outcomes from ICD implantation with hospitals of similar procedure volume and a national aggregate. Several important research studies have been published highlighting the use of ICDs in the general population outside the constraints of randomized clinical trials and assessing procedural-related outcomes among providers with different training. The National ICD Registry is being assessed for use as a performance measure reporting tool and Version 2.0 has been developed and will be in general use in early 2010. This expanded version of the registry improves the data collection form, correcting concerns from the initial data entry form, adding elements that were missing, and expanding the data to include ICD and pacemaker leads and pediatric ICD implantation.",
author = "Hammill, {Stephen C.} and Kremers, {Mark S.} and Kadish, {Alan H.} and Stevenson, {Lynne Warner} and Heidenreich, {Paul A.} and Lindsay, {Bruce D.} and Mirro, {Michael J.} and Radford, {Martha J.} and Chuck McKay and Yongfei Wang and Lang, {Christine M.} and Kathryn Pontzer and John Rumsfeld and Phurrough, {Steve E.} and Curtis, {Jeptha P.} and Brindis, {Ralph G.}",
note = "Funding Information: For this reason the Longitudinal ICD Registry Study was developed by the National ICD Registry Working Group and approved by CMS in May 2007. The study is designed to follow a cohort of 3,500 Medicare beneficiaries receiving a primary prevention ICD with a primary end point of the first delivery of an appropriate ICD therapy including ICD shock or anti-tachycardia pacing. Secondary end points include survival at three and five years; death from any cardiovascular cause; total number and rate of device therapies; and ratio of inappropriate to total device therapy. The planned followup is three years for events and five years for survival with an adjudication process in place to review events. Funding for the Longitudinal ICD Registry Study has been challenging but has now been secured from the National Institutes of Health, AHRQ, industry, and America's Health Insurance Plans (AHIP). The study is being run by the Cardiovascular Research Network (CVRN), which is a national effort that leverages the collective cardiovascular expertise, diverse community based study population, and rich electronic data systems within the HMO Research Network to better study the epidemiology, prevention, management and outcomes of cardiovascular diseases. ",
year = "2009",
month = sep,
doi = "10.1016/j.hrthm.2009.07.015",
language = "English (US)",
volume = "6",
pages = "1397--1401",
journal = "Heart Rhythm",
issn = "1547-5271",
publisher = "Elsevier",
number = "9",
}